NCT07070713 2025-07-17
Efficacy and Safety of FOLFOX+Cetuximab vs. FOLFOXIRI+Bevacizumab Both With QL1706 in First-Line Treatment of Left-Sided mCRC
Fujian Cancer Hospital
Phase 2 Not yet recruiting
Clinical Trials
1 trialsNot yet recruiting × Metastatic Colorectal Cancer With Left-sided Primary Tumor × Bevacizumab × Clear all